In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump Closes Down Manufacturing Advisory Panel Following CEO Exodus

This article is powered by The Rose Sheet

Executive Summary

Trump's American Manufacturing Council began losing members daily after the president's perceived failure to address racially charged violence in Charlottesville, Virginia. J&J CEO Alex Gorsky was among business leaders who opted to stick with the advisory panel, a position that triggered mass calls for boycotts online.

You may also be interested in...



Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back

The US president made what seemed to be a retaliatory statement about high drug prices after Merck CEO Ken Frazier resigned from his jobs council.

J&J ‘Encouraged’ By Prospect Of Corporate Tax Reform Following Trump Meeting

Johnson & Johnson CEO Alex Gorsky took the occasion of the firm’s fourth-quarter and year-end earnings call to discuss key policy issues in the US following a “productive” meeting between business leaders and President Trump.

PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises

The Personal Care Products Council outlines a list of “principles” that it believes should guide legislation to update cosmetics regulations. Many of its priorities could be seen as aligning more closely with reintroduced House legislation than the less industry-friendly Personal Care Products Safety Act in the previous Senate, signaling a possible change in strategic direction at PCPC under the new Administration.

Topics

Related Companies

UsernamePublicRestriction

Register

SC066183

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel